Investigating Microperimetric Features in Bietti Crystalline Dystrophy Patients: A Cross-Sectional Longitudinal Study in a Large Cohort
Investigative Ophthalmology & Visual Science · 2024
DOI: 10.1167/iovs.65.13.27 ↗At a glance
Querschnittstudie in Investigative Ophthalmology & Visual Science, 2024. Written by Yufei Xu and 12 co-authors. Institution: Southwest Hospital/Southwest Eye Hospital, Third Military Medical University (Army Medical University), Chongqing, China. Major MEDLINE topics: Tomography, Optical Coherence, Visual Field Tests, Visual Acuity, Corneal Dystrophies, Hereditary. Cited 4 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
To assess the clinical and genetic characteristics of patients with Bietti crystalline dystrophy (BCD) with a focus on potential of microperimetry in monitoring macular function.
Methods
A total of 208 genetically-confirmed BCD patients were enrolled in this retrospective study. The patients were categorized into subgroups based on their fundus characteristics (fovea sparing and fovea involved), optical coherence tomography (OCT) findings (presence/absence of retinal pigment epithelium [RPE] or ellipsoid zone [EZ] line at the fovea/parafovea), and genetic profiles (Mis/Mis, Tru/Mis, Tru/Tru). Fixation patterns were analyzed, and macular sensitivity (MS) parameters were compared among different groups. Longitudinal analysis was performed to calculate the annual changes in MS parameters. Correlation between genotype and phenotype were further investigated by analyzing cumulative incidence of vision impairment among different genotypic groups.
Results
Patients with well-preserved RPE or EZ at the foveal/parafoveal region exhibited higher MS. Notably, there was a decline in sensitivity parameters, with a decrease of -2.193 dB/year (95% confidence interval [CI] -4.292 to -0.095, P = 0.041) at the fovea and -1.353 dB/year (95% CI -2.047 to -0.659, P < 0.001) in average sensitivity. An age-adjusted comparison of sensitivity among genotypic groups and cumulative incidence analyses showed no association between genotypic groups and vision loss.
Conclusions
Microperimetry proves to be one of a credible tool for detecting macular functional changes in BCD patients. BCD patients with different genotypes may have similar disease progression.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Southwest Hospital/Southwest Eye Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
- Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Chongqing, China.
- Jinfeng Laboratory, Chongqing, China.
- Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research, Singapore, Singapore.
- Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
- Department of Ophthalmology, National University Hospital, Singapore, Singapore.
Cite
APA
Xu, Y., Liu, X., Wu, N., Long, Y., Ren, J., Wang, Y., Su, X., Liu, Z., Fujinami-Yokokawa, Y., Fujinami, K., Chen, F., Meng, X., & Liu, Y. (2024). Investigating Microperimetric Features in Bietti Crystalline Dystrophy Patients: A Cross-Sectional Longitudinal Study in a Large Cohort. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.13.27
Vancouver
Xu Y, Liu X, Wu N, Long Y, Ren J, Wang Y, et al. Investigating Microperimetric Features in Bietti Crystalline Dystrophy Patients: A Cross-Sectional Longitudinal Study in a Large Cohort. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.13.27
BibTeX
@article{Xu2024,
author = {Xu, Yufei and Liu, Xiao and Wu, Nan and Long, Yanling and Ren, Jiayun and Wang, Yu and Su, Xinyi and Liu, Zengping and Fujinami-Yokokawa, Yu and Fujinami, Kaoru and Chen, Fang and Meng, Xiaohong and Liu, Yong},
title = {Investigating Microperimetric Features in Bietti Crystalline Dystrophy Patients: A Cross-Sectional Longitudinal Study in a Large Cohort},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
doi = {10.1167/iovs.65.13.27}
}
EUVIMED